News

The FDA and CBD, Everything You Need to Know

March 10, 2020

In Episode 2 of the U.S. Hemp Roundtable’s new podcast, Hemp Table Talk, The Roundtable’s General Counsel, Jonathan Miller, and the FDA Counsel, Rend Al-Mondhiry, discuss the current state of the FDA's perspective on CBD and CBD-based products. During the podcast, they interview Front Range Biosciences' CEO and Co-Founder, Dr. Jonathan Vaught, to learn about his experience testifying at the FDA's public hearing on cannabis-derived compounds in May 2019. Dr. Vaught explains how developing a regulatory framework would provide clarity for companies aiming to produce products containing CBD as a dietary supplement or food additive.

Listen to the full podcast to learn more.

ADDITIONAL INFORMATION:
  • Searching for cannabinoid-rich hemp plants? To view our current availability for cannabinoid-rich clones from our Clean Stock® program, as well as our seedlings and feminized seeds, contact our sales team at: sales@frontrangebio.com or complete an order inquiry at: https://www.frontrangebio.com/inquire
  • Stay up-to-date with FRB’s current events and information by following our Resources page